✦ LIBER ✦

Diffusion imaging for evaluation of tumor therapies in preclinical animal models

✍ Scribed by B. A. Moffat; D. E. Hall; J. Stojanovska; P. J. McConville; J. B. Moody; T. L. Chenevert; A. Rehemtulla; B. D. Ross

Publisher: Springer
Year: 2004
Tongue: English
Weight: 681 KB
Volume: 17
Category: Article
ISSN: 0968-5243
DOI: 10.1007/s10334-004-0079-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advances in preclinical therapeutics dev

Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model

✍ M. A. Pantaleo; L. Landuzzi; G. Nicoletti; C. Nanni; S. Boschi; G. Piazzi; D. Sa 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 411 KB

Imaging of QDs-labeled tumors in small a

Imaging of QDs-labeled tumors in small animals by fluorescence diffuse tomography

✍ I. V. Turchin; I. V. Balalaeva; R. B. Vasil'ev; V. P. Zlomanov; V. I. Plehanov; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Quantum dots (QD) are a new class of fluorescence labels with properties and biomedical applications that are not available with traditional organic dyes and fluorescent proteins. The unique optical properties of QDs (high absorption, quantum yield and emission spanning to near IR) make them attract

Alloantigen gene therapy for head and ne

Alloantigen gene therapy for head and neck cancer: Evaluation of animal models

✍ Lyon L. Gleich; Ya-Qin Li; Shunan Li; Jack L. Gluckman; Peter J. Stambrook 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

## Background: Human trials of alloantigen gene therapy, using the class i major histocompatibility complex (mhc) hla-b7, have demonstrated the potential efficacy of this treatment for head and neck cancer. its mechanism remains unclear. an immune-competent mouse model of mhc gene therapy to test f

Hypericin-mediated photodynamic therapy

Hypericin-mediated photodynamic therapy of pituitary tumors: preclinical study in a GH4C1 rat tumor model

✍ Chad D. Cole; James K. Liu; Xiaoming Sheng; Steven S. Chin; Meic H. Schmidt; Mar 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 274 KB

Modeling of congenital erythropoietic po

Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation

✍ Elodie Robert-Richard; Magalie Lalanne; Isabelle Lamrissi-Garcia; Véronique Guyo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

## Abstract ## Background Congenital erythropoietic porphyria (CEP) is a severe autosomal recessive disorder characterized by a deficiency in uroporphyrinogen III synthase (UROS), the fourth enzyme of the heme biosynthetic pathway. We recently demonstrated the definitive cure of a murine model of

An animal model for in vivo evaluation o

An animal model for in vivo evaluation of tumor glycolytic rates with positron emission tomography

✍ Dr. Randall A. Hawkins; Yong Choi; Steven Scates; Sheila Rege; Carl K. Hoh; John 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

## Abstract We developed a method for evaluating tumor glycolytic rates in vivo with nude mice injected with 2‐[F‐18]fluoro‐2‐deoxy‐d‐glucose (FDG) and a dedicated animal positron emission tomography (PET) scanner. Animals were injected with NR‐6 mouse fibroblast tumor cell lines. When tumors achie